On Friday, the FDA and the Reagan-Udall Foundation for the FDA announced a public meeting on October 4 titled, “Mitigating Risks from Human Xylazine Exposure”. 

Read more

The Reagan-Udall Foundation plans to release a commissioner-requested report on Oct. 5 — as long as the federal government doesn’t shut down — outlining how the FDA can more effectively combat misinformation, the group’s leader said this week.

Read more

Research Director Carla Rodriguez Watson, PhD, MPH continues the RAISE conversation about race and ethnicity data in healthcare. 

Listen to the podcast